InvestorsHub Logo
Followers 73
Posts 6214
Boards Moderated 0
Alias Born 05/01/2011

Re: None

Friday, 12/13/2019 1:03:25 PM

Friday, December 13, 2019 1:03:25 PM

Post# of 426455
Having now read the thing more carefully, I think it is entirely reasonable to suggest that the FDA may already have notified AMRN of the approval and the specific label.

It is also entirely reasonble to suggest that AMRN is preparing a PR and will release it after the close today or first thing Monday morning.

AND it is extremely unlikely that that label is narrower than the eligibility for the REDUCE-IT trial.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News